MedPath

CeQur Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Device: PaQ® Insulin Delivery Device
Drug: Insulin, Asp(B28)-
First Posted Date
2015-04-17
Last Posted Date
2016-07-26
Lead Sponsor
CeQur Corporation
Target Recruit Count
20
Registration Number
NCT02419859
Locations
🇦🇹

Medical University of Graz, Graz, Austria

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

Terminated
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2014-06-06
Last Posted Date
2016-07-26
Lead Sponsor
CeQur Corporation
Target Recruit Count
8
Registration Number
NCT02158078
Locations
🇦🇹

Medical University of Graz, Graz, Austria

Study of PaQ™ (a Simple Patch on Insulin Delivery Device) in Patients With Type 2 Diabetes Mellitus

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Device: PaQ™ insulin infusion device
First Posted Date
2012-02-20
Last Posted Date
2016-07-27
Lead Sponsor
CeQur Corporation
Target Recruit Count
20
Registration Number
NCT01535612
Locations
🇦🇹

Medical University of Graz, Graz, Austria

© Copyright 2025. All Rights Reserved by MedPath